| |  | | | | | | | | | | | | | | | |  | | | | | | | | | | | | | | | | | | | | | | | | Directors of the California stem cell agency appear ready to commission a $1 million "gold standard" study of its operations with the hope that it will pave the way for voter approval of billions more for stem cell research, perhaps as early as November 2012. The proposal is scheduled to be voted on at the CIRM board meeting next Wednesday and Thursday meeting at Stanford. However, few details | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Author and Harvard business professor Rosabeth Moss Kanter weighed in this week on "big traps in small lapses." The case in point was the recent resignation of HP CEO Mark Hurd, a man who made more than $66,000 a day, because he fudged a $20,000 expense report. Kanter asked, "How can very smart, accomplished people do such stupid things?"Kanter, whose 18 books have won her recognition as one | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |  Shlomo Melmed The governing board for the $3 billion California stem cell agency has a new member – Shlomo Melmed, who is senior vice president for academic affairs and dean of the medical faculty at Cedars-Sinai Medical Center in Los Angeles. Gov. Arnold Schwarzenegger named Melmed to replace Ricardo Azziz, who left California to head the Medical College of Georgia. Azziz was also a top | | | | | | | | | | |  |
No comments:
Post a Comment